Company / Free Cash Flow per Share
Beta Bionics, Inc. Free Cash Flow per Share History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
-$8.43
FY2025
5-year range
-$9.74 / -$6.19
FY2023-FY2025
Trend
+13.4%
vs FY2024
Sector context
#146 of 148
Health Care
What the data says
Among 148 Health Care companies, Beta Bionics, Inc. is in the bottom 1% for free cash flow per share. Declined from $-6.19 to $-8.43 over the past 2 years.
Based on SEC 10-K filings.
-8.43 in FY2025.
Declined from $-6.19 to $-8.43 over the past 2 years.
Health Care sector context is included.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 1% in Health CareTop 99% of 148This company -$8.43 Sector average $5.05
▼
-267.0% below sector average
Key checks
Key Insights
- In FY2025, free cash flow per share increased 13.4% year-over-year.
- Ranks #146 out of 148 companies in the Health Care sector.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$8.43 | +13.4% |
| FY2024 | -$9.74 | -57.3% |
| FY2023 | -$6.19 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026